(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Avenue Therapeutics, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Monday, March 31st, 2025 | Fortress Biotech, Inc. | 10 percent owner | 328,524 | A-Award | A | 33,724 | 0.00 USD | 0 USD |
| Tuesday, December 31st, 2024 | Fortress Biotech, Inc. | 10 percent owner | 294,800 | 0 | 0.00 USD | 0 USD | ||
| Monday, December 2nd, 2024 | Herskowitz Neil | director | 97 | S-Sale | D | 23 | 2.00 USD | 46 USD |
| Tuesday, November 5th, 2024 | KRANZLER JAY D | director | 559 | S-Sale | D | 61 | 2.24 USD | 137 USD |
| Monday, September 30th, 2024 | KRANZLER JAY D | director | 620 | P-Purchase | A | 497 | 2.50 USD | 1,243 USD |
| Friday, September 27th, 2024 | KRANZLER JAY D | director | 123 | P-Purchase | A | 3 | 2.40 USD | 7 USD |
| Monday, September 23rd, 2024 | ROSENWALD LINDSAY A MD | director | 30,000 | A-Award | A | 30,000 | 2.46 USD | 73,800 USD |
| Monday, September 23rd, 2024 | Herskowitz Neil | director | 30,000 | A-Award | A | 30,000 | 2.46 USD | 73,800 USD |
| Monday, September 23rd, 2024 | Oltmans Curtis Gale | director | 30,000 | A-Award | A | 30,000 | 2.46 USD | 73,800 USD |
| Monday, September 23rd, 2024 | MacLean Alexandra | director, officer: Chief Executive Officer | 170,000 | A-Award | A | 170,000 | 0.00 USD | 0 USD |
| Monday, September 23rd, 2024 | KRANZLER JAY D | director | 30,000 | A-Award | A | 30,000 | 2.46 USD | 73,800 USD |
| Monday, September 23rd, 2024 | Jin David | officer: Interim PFO and COO | 65,000 | A-Award | A | 65,000 | 0.00 USD | 0 USD |
| Monday, September 23rd, 2024 | Charles Faith L. | director | 30,000 | A-Award | A | 30,000 | 2.46 USD | 73,800 USD |
| Tuesday, April 16th, 2024 | Fortress Biotech, Inc. | 10 percent owner | 3,547,393 | A-Award | A | 413,507 | 0.00 USD | 0 USD |
| Tuesday, January 2nd, 2024 | Fortress Biotech, Inc. | 10 percent owner | 3,133,886 | A-Award | A | 2,101,496 | 0.00 USD | 0 USD |
| Monday, December 11th, 2023 | Davidow Robert L | 10 percent owner | 681,000 | S-Sale | D | 264,000 | 0.14 USD | 36,960 USD |
| Monday, December 11th, 2023 | Davidow Robert L | 10 percent owner | 215,800 | S-Sale | D | 126,000 | 0.14 USD | 17,640 USD |
| Monday, December 11th, 2023 | Davidow Robert L | 10 percent owner | 147,000 | S-Sale | D | 128,000 | 0.14 USD | 17,920 USD |
| Monday, December 11th, 2023 | Davidow Robert L | 10 percent owner | 80,000 | S-Sale | D | 20,000 | 0.14 USD | 2,800 USD |
| Monday, December 11th, 2023 | Davidow Robert L | 10 percent owner | 74,000 | S-Sale | D | 61,000 | 0.14 USD | 8,540 USD |
| Monday, December 11th, 2023 | Davidow Robert L | 10 percent owner | 22,000 | S-Sale | D | 18,000 | 0.15 USD | 2,700 USD |
| Tuesday, October 31st, 2023 | Davidow Robert L | 10 percent owner | 945,000 | D | 0 | 0.00 USD | 0 USD | |
| Tuesday, October 31st, 2023 | Davidow Robert L | 10 percent owner | 341,800 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, October 31st, 2023 | Davidow Robert L | 10 percent owner | 275,000 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, October 31st, 2023 | Davidow Robert L | 10 percent owner | 135,000 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, October 31st, 2023 | Davidow Robert L | 10 percent owner | 100,000 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, October 31st, 2023 | Davidow Robert L | 10 percent owner | 90,000 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, October 31st, 2023 | Davidow Robert L | 10 percent owner | 40,000 | I | 0 | 0.00 USD | 0 USD | |
| Friday, September 8th, 2023 | ROSENWALD LINDSAY A MD | director | 354,318 | P-Purchase | A | 348,675 | 0.72 USD | 251,046 USD |
| Friday, September 8th, 2023 | Fortress Biotech, Inc. | 10 percent owner | 1,032,390 | P-Purchase | A | 418,410 | 0.72 USD | 301,255 USD |
| Friday, June 30th, 2023 | Charles Faith L. | director | 100,000 | A-Award | A | 100,000 | 1.14 USD | 114,000 USD |
| Friday, June 30th, 2023 | Jin David | officer: Interim PFO and COO | 250,000 | A-Award | A | 250,000 | 1.14 USD | 285,000 USD |
| Friday, June 30th, 2023 | ROSENWALD LINDSAY A MD | director | 100,000 | A-Award | A | 100,000 | 1.14 USD | 114,000 USD |
| Friday, June 30th, 2023 | KRANZLER JAY D | director | 100,000 | A-Award | A | 100,000 | 1.14 USD | 114,000 USD |
| Friday, June 30th, 2023 | Oltmans Curtis Gale | director | 100,000 | A-Award | A | 100,000 | 1.14 USD | 114,000 USD |
| Friday, June 30th, 2023 | Herskowitz Neil | director | 100,000 | A-Award | A | 100,000 | 1.14 USD | 114,000 USD |
| Thursday, June 29th, 2023 | MacLean Alexandra | director, officer: Chief Executive Officer | 800,000 | A-Award | A | 800,000 | 1.14 USD | 912,000 USD |
| Friday, March 31st, 2023 | Fortress Biotech, Inc. | 10 percent owner | 613,980 | A-Award | A | 52,419 | 0.00 USD | 0 USD |
| Tuesday, January 3rd, 2023 | Fortress Biotech, Inc. | director | 561,561 | A-Award | A | 231,316 | 0.00 USD | 0 USD |
| Saturday, December 31st, 2022 | Fortress Biotech, Inc. | director | 330,245 | A-Award | A | 90,909 | 0.00 USD | 0 USD |
| Tuesday, October 11th, 2022 | InvaGen Pharmaceuticals, Inc. | director | 0 | S-Sale | D | 388,888 | 7.71 USD | 2,999,882 USD |
| Monday, August 1st, 2022 | MacLean Alexandra | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Wednesday, May 11th, 2022 | Jin David | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Monday, May 16th, 2022 | Charles Faith L. | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, December 17th, 2021 | KRANZLER JAY D | director | 133,683 | A-Award | A | 20,000 | 0.00 USD | 0 USD |
| Friday, December 17th, 2021 | KRANZLER JAY D | director | 113,683 | A-Award | A | 49,020 | 0.00 USD | 0 USD |
| Friday, December 17th, 2021 | Herskowitz Neil | director | 183,744 | A-Award | A | 20,000 | 0.00 USD | 0 USD |
| Friday, December 17th, 2021 | Herskowitz Neil | director | 163,744 | A-Award | A | 49,020 | 0.00 USD | 0 USD |
| Friday, December 17th, 2021 | Oltmans Curtis Gale | director | 49,020 | A-Award | A | 49,020 | 0.00 USD | 0 USD |
| Thursday, April 1st, 2021 | Oltmans Curtis Gale | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, December 17th, 2021 | Lu Lucy | director, officer: President, CEO | 748,949 | A-Award | A | 411,616 | 0.00 USD | 0 USD |
| Friday, December 17th, 2021 | Vazzano Joseph Walter | officer: Chief Financial Officer | 165,757 | A-Award | A | 100,505 | 0.00 USD | 0 USD |
| Wednesday, September 15th, 2021 | Vazzano Joseph Walter | officer: Chief Financial Officer | 65,252 | S-Sale | D | 7,160 | 1.62 USD | 11,599 USD |
| Thursday, May 6th, 2021 | Herskowitz Neil | director | 134,724 | P-Purchase | A | 2,500 | 3.99 USD | 9,975 USD |
| Thursday, August 20th, 2020 | Vazzano Joseph Walter | officer: Chief Financial Officer | 57,412 | S-Sale | D | 3,840 | 12.13 USD | 46,579 USD |
| Tuesday, June 16th, 2020 | KRANZLER JAY D | director | 84,663 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
| Tuesday, June 16th, 2020 | Herskowitz Neil | director | 132,224 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
| Tuesday, March 10th, 2020 | Vazzano Joseph Walter | officer: Chief Financial Officer | 61,252 | P-Purchase | A | 1,889 | 7.94 USD | 14,999 USD |
| Monday, March 9th, 2020 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,363 | P-Purchase | A | 100 | 7.97 USD | 797 USD |
| Monday, March 9th, 2020 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,263 | P-Purchase | A | 1,400 | 7.99 USD | 11,186 USD |
| Thursday, February 27th, 2020 | Herskowitz Neil | director | 122,224 | P-Purchase | A | 2,400 | 8.20 USD | 19,680 USD |
| Wednesday, February 26th, 2020 | Herskowitz Neil | director | 119,824 | P-Purchase | A | 161 | 8.73 USD | 1,406 USD |
| Tuesday, February 25th, 2020 | Vazzano Joseph Walter | officer: Chief Financial Officer | 57,863 | P-Purchase | A | 1,200 | 9.09 USD | 10,908 USD |
| Tuesday, February 25th, 2020 | Herskowitz Neil | director | 119,663 | P-Purchase | A | 10,000 | 9.31 USD | 93,100 USD |
| Wednesday, February 12th, 2020 | Vazzano Joseph Walter | officer: Chief Financial Officer | 50,505 | A-Award | A | 22,727 | 0.00 USD | 0 USD |
| Wednesday, February 12th, 2020 | Lu Lucy | director, officer: President, CEO | 246,576 | A-Award | A | 110,959 | 0.00 USD | 0 USD |
| Friday, February 8th, 2019 | InvaGen Pharmaceuticals, Inc. | 5,833,333 | D | 0 | 0.00 USD | 0 USD | ||
| Friday, February 8th, 2019 | InvaGen Pharmaceuticals, Inc. | 3,923,429 | I | 0 | 0.00 USD | 0 USD | ||
| Friday, February 8th, 2019 | InvaGen Pharmaceuticals, Inc. | 250,000 | I | 0 | 0.00 USD | 0 USD | ||
| Friday, February 8th, 2019 | InvaGen Pharmaceuticals, Inc. | 0 | I | 135,617 | 0.00 USD | 0 USD | ||
| Thursday, September 12th, 2019 | Ingram Elizabeth Garrett | director | 16,000 | P-Purchase | A | 16,000 | 6.27 USD | 100,320 USD |
| Tuesday, August 27th, 2019 | KRANZLER JAY D | director | 74,663 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
| Tuesday, August 27th, 2019 | Herskowitz Neil | director | 109,663 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
| Thursday, August 8th, 2019 | Vazzano Joseph Walter | officer: Chief Financial Officer | 59,038 | S-Sale | D | 2,313 | 5.62 USD | 12,999 USD |
| Friday, August 9th, 2019 | Vazzano Joseph Walter | officer: Chief Financial Officer | 56,663 | S-Sale | D | 2,375 | 5.56 USD | 13,205 USD |
| Thursday, August 1st, 2019 | Ingram Elizabeth Garrett | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Tuesday, June 18th, 2019 | Herskowitz Neil | director | 99,663 | P-Purchase | A | 2,000 | 5.83 USD | 11,660 USD |
| Monday, June 17th, 2019 | Herskowitz Neil | director | 97,663 | P-Purchase | A | 3,000 | 5.88 USD | 17,640 USD |
| Monday, June 3rd, 2019 | Vazzano Joseph Walter | officer: Chief Financial Officer | 27,778 | A-Award | A | 27,778 | 0.00 USD | 0 USD |
| Monday, June 3rd, 2019 | Lu Lucy | director, officer: President, CEO | 135,617 | A-Award | A | 135,617 | 0.00 USD | 0 USD |
| Tuesday, April 30th, 2019 | Moore Thomas Gregory | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Monday, April 15th, 2019 | Herskowitz Neil | director | 94,663 | P-Purchase | A | 1,000 | 4.52 USD | 4,520 USD |
| Friday, March 29th, 2019 | Herskowitz Neil | director | 93,663 | P-Purchase | A | 1,400 | 5.11 USD | 7,154 USD |
| Thursday, March 28th, 2019 | Herskowitz Neil | director | 92,263 | P-Purchase | A | 600 | 5.11 USD | 3,066 USD |
| Monday, February 25th, 2019 | Herskowitz Neil | director | 91,663 | P-Purchase | A | 5,000 | 5.46 USD | 27,300 USD |
| Friday, February 8th, 2019 | Gogtay Jaideep Ashok | 0 | 0 | 0.00 USD | 0 USD | |||
| Friday, February 8th, 2019 | Saxena Nishant | 0 | 0 | 0.00 USD | 0 USD | |||
| Tuesday, February 5th, 2019 | Herskowitz Neil | director | 86,663 | P-Purchase | A | 1,850 | 5.77 USD | 10,675 USD |
| Monday, February 4th, 2019 | Herskowitz Neil | director | 84,813 | P-Purchase | A | 7,000 | 5.91 USD | 41,370 USD |
| Wednesday, January 30th, 2019 | Herskowitz Neil | director | 77,813 | P-Purchase | A | 650 | 5.91 USD | 3,842 USD |
| Tuesday, January 29th, 2019 | Herskowitz Neil | director | 77,163 | P-Purchase | A | 8,553 | 5.91 USD | 50,548 USD |
| Monday, January 28th, 2019 | Herskowitz Neil | director | 68,610 | P-Purchase | A | 1,447 | 5.84 USD | 8,451 USD |
| Monday, December 10th, 2018 | Paley Jeffrey | director | 79,663 | P-Purchase | A | 5,000 | 4.76 USD | 23,800 USD |
| Monday, December 3rd, 2018 | Paley Jeffrey | director | 74,663 | P-Purchase | A | 10,000 | 5.48 USD | 54,754 USD |
| Tuesday, August 7th, 2018 | Vazzano Joseph Walter | officer: VP Finance & Corp. Controller | 61,351 | G-Gift | A | 30,000 | 0.00 USD | 0 USD |
| Tuesday, August 7th, 2018 | Lu Lucy | director, officer: President, CEO | 807,333 | G-Gift | A | 250,000 | 0.00 USD | 0 USD |
| Tuesday, August 7th, 2018 | ROSENWALD LINDSAY A MD | director | 84,663 | G-Gift | A | 14,663 | 0.00 USD | 0 USD |
| Tuesday, August 7th, 2018 | Herskowitz Neil | director | 67,163 | G-Gift | A | 14,663 | 0.00 USD | 0 USD |
| Tuesday, August 7th, 2018 | KRANZLER JAY D | director | 64,663 | G-Gift | A | 14,663 | 0.00 USD | 0 USD |
| Tuesday, August 7th, 2018 | Reines Scott | officer: Interim Chief Medical Officer | 45,000 | G-Gift | A | 10,000 | 0.00 USD | 0 USD |
